TC BioPharm (Holdings) plc (NASDAQ: TCBP)
$0.84
+0.0210 ( +2.56% ) 19.7K
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Market Data
Open
$0.84
Previous close
$0.82
Volume
19.7K
Market cap
$4.20M
Day range
$0.80 - $0.85
52 week range
$0.72 - $19.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jan 04, 2024 |
6-k | Quarterly Reports | 7 | Dec 21, 2023 |
6-k | Quarterly Reports | 2 | Dec 13, 2023 |
6-k | Quarterly Reports | 84 | Nov 02, 2023 |
6-k | Quarterly Reports | 3 | Aug 31, 2023 |
6-k | Quarterly Reports | 1 | Aug 22, 2023 |
6-k | Quarterly Reports | 1 | Jul 31, 2023 |
6-k | Quarterly Reports | 7 | Jul 24, 2023 |
6-k | Quarterly Reports | 1 | Jul 10, 2023 |